Skip to content

Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)

Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04768920
Enrollment
50
Registered
2021-02-24
Start date
2022-11-11
Completion date
2026-08-18
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Dependence, Substance Use, Substance Use Disorders

Keywords

Telehealth, Motivational interviewing, Cognitive behavioral therapy

Brief summary

The objective of this pilot intervention study is to iteratively refine motivational interviewing and psychosocial intervention programs delivered via telehealth (Teletx) to help improve substance use and other related outcomes in SUD patients who are not receiving SUD care. We will examine feasibility and acceptability of these pilot psychosocial programs in a total of n=50 participants. The goal is to refine the programs to improve acceptability and feasibility and collect preliminary data for a future fully powered randomized controlled trial (RCT) in the future. In addition to study sessions, participants that are enrolled in the study will complete surveys prior to, during, and after treatment.

Interventions

BEHAVIORALMI-CBT Teletx

Participants will first receive a 20-45 min phone or video session focused on raising participants' motivation to engage in treatment activities and psychoeducation material about substance use (i.e. "engagement session") including possible discussion about risks of substance use, value of alternative healthier activities, and the community and crisis resources pamphlet. The evidence-based manualized psychosocial programs that will be delivered via telehealth are adaptations of cognitive behavioral therapy, motivational interviewing, and other psychosocial interventions to enhance initial and ongoing treatment engagement. TeleTx consists of up to 8 \~30-50 minute psychosocial sessions delivered via phone or videoconference platform (e.g. Zoom etc)

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Outpatient care at Michigan Medicine in past year * Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month * Have a Smart phone, tablet or another Wi-Fi or data-enabled device (e.g. with a camera)

Exclusion criteria

* Inability to speak or understand English * Conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content * Prior alcohol withdrawal seizures or delirium tremens (DTs). Those who are at-risk of complicated withdrawal (e.g., seizures, DTs) require greater medical attention and will be excluded and referred to their clinician for medical management.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the intervention (engagement)8 weeksPercent (%) of participants engaging in the intervention
Tele-Tx Intervention acceptability8 weeksStudy-specific acceptability rating completed by participants. Based on Likert scale, higher scores indicate greater treatment acceptability

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAllison Lin, MD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026